Biochemical Characterization of Patients With In-Frame or Out-of-FrameDMDDeletions Pertinent to Exon 44 or 45 Skipping-Reference-Cited by-同舟云学术

Biochemical Characterization of Patients With In-Frame or Out-of-FrameDMDDeletions Pertinent to Exon 44 or 45 Skipping

Published:2014-01-01 Issue:1 Volume:71 Page:32
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Anthony Karen¹,Arechavala-Gomeza Virginia¹,Ricotti Valeria¹,Torelli Silvia¹,Feng Lucy¹,Janghra Narinder¹,Tasca Giorgio²,Guglieri Michela³,Barresi Rita³,Armaroli Annarita⁴,Ferlini Alessandra⁴,Bushby Katherine³,Straub Volker³,Ricci Enzo⁵,Sewry Caroline¹,Morgan Jennifer¹,Muntoni Francesco¹

Affiliation:

1. Dubowitz Neuromuscular Centre, Institute of Child Health, University College London, London, England

2. Don Carlo Gnocchi Onlus Foundation, Milan, Italy

3. Institute of Genetic Medicine, Newcastle University, Newcastle, England

4. Section of Medical Genetics, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy

5. Institute of Neurology, Catholic University, Rome, Italy

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I/II Trial of Brogidirsen: Dual-Targeting Antisense Oligonucleotides for Exon 44 Skipping in Duchenne Muscular Dystrophy;2024-08-30

2. Identification of hub genes and therapeutic siRNAs to develop novel adjunctive therapy for Duchenne muscular dystrophy;BMC Musculoskeletal Disorders;2024-05-18

3. Neuromuscular disorders in the omics era;Clinica Chimica Acta;2024-01

4. A 1-year analysis from a natural history study in Chinese individuals with Duchenne muscular dystrophy;The Lancet Regional Health - Western Pacific;2024-01

5. Deletion of exons 45 to 55 in theDMDgene: from the therapeutic perspective to thein vitromodel;2023-09-14